1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL IN-VITRO DIAGNOSTICS MARKET BY TECHNIQUE
5.1. Introduction
5.2. Immunoassay
5.3. Molecular Diagnostics
5.4. Hematology
5.5. Others
6. GLOBAL IN-VITRO DIAGNOSTICS MARKET BY APPLICATION
6.1. Introduction
6.2. Infectious diseases
6.3. Autoimmune diseases
6.4. Drug Testing
6.5. Oncology
6.6. Others
7. GLOBAL IN-VITRO DIAGNOSTICS MARKET BY END-USER
7.1. Introduction
7.2. Diagnostic Laboratories
7.3. Hospitals and Clinics
7.4. Research Laboratories and Institutes
8. GLOBAL IN-VITRO DIAGNOSTICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Technique
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Technique
8.3.2. By Application
8.3.3. By End User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Technique
8.4.2. By Application
8.4.3. By End User
8.4.4. By Country
8.4.4.1. Germany
8.4.4.2. France
8.4.4.3. United Kingdom
8.4.4.4. Italy
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Technique
8.5.2. By Application
8.5.3. By End User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. UAE
8.5.4.3. Israel
8.5.4.4. Others
8.6. Asia Pacific
8.6.1. By Technique
8.6.2. By Application
8.6.3. By End User
8.6.4. By Country
8.6.4.1. China
8.6.4.2. Japan
8.6.4.3. South Korea
8.6.4.4. India
8.6.4.5. Australia
8.6.4.6. Taiwan
8.6.4.7. Thailand
8.6.4.8. Indonesia
8.6.4.9. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Roche Diagnostics
10.2. Plasmatec
10.3. Vitro Bio
10.4. Omega Diagnostics Group PLC & Technologien GmbH
10.5. DST Diagnostische Systeme
10.6. SD Biosensor
10.7. Abbott Diagnostics
10.8. Meril Diagnostics
10.9. NIPPON GENE CO., LTD.
10.10. Rapid Diagnostics Group of Companies